- Home
- CBUS vs GUTS Comparison
CBUS vs GUTS Comparison
Compare CBUS & GUTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBUS
- GUTS
- Stock Information
- Founded
- CBUS 2010
- GUTS 2010
- Country
- CBUS United States
- GUTS United States
- Employees
- CBUS N/A
- GUTS N/A
- Industry
- CBUS Agricultural Chemicals
- GUTS
- Sector
- CBUS Industrials
- GUTS
- Exchange
- CBUS Nasdaq
- GUTS NYSE
- Market Cap
- CBUS 65.3M
- GUTS 58.8M
- IPO Year
- CBUS 2017
- GUTS 2024
- Fundamental
- Price
- CBUS $1.55
- GUTS $1.67
- Analyst Decision
- CBUS Strong Buy
- GUTS Buy
- Analyst Count
- CBUS 3
- GUTS 1
- Target Price
- CBUS $22.00
- GUTS $10.00
- AVG Volume (30 Days)
- CBUS 927.1K
- GUTS 942.7K
- Earning Date
- CBUS 08-07-2025
- GUTS 08-13-2025
- Dividend Yield
- CBUS N/A
- GUTS N/A
- EPS Growth
- CBUS N/A
- GUTS N/A
- EPS
- CBUS N/A
- GUTS N/A
- Revenue
- CBUS $4,751,000.00
- GUTS $60,000.00
- Revenue This Year
- CBUS $32.97
- GUTS N/A
- Revenue Next Year
- CBUS $66.40
- GUTS N/A
- P/E Ratio
- CBUS N/A
- GUTS N/A
- Revenue Growth
- CBUS 104.78
- GUTS N/A
- 52 Week Low
- CBUS $1.38
- GUTS $0.87
- 52 Week High
- CBUS $10.77
- GUTS $4.92
- Technical
- Relative Strength Index (RSI)
- CBUS 42.57
- GUTS 44.68
- Support Level
- CBUS $1.40
- GUTS $1.56
- Resistance Level
- CBUS $1.67
- GUTS $1.82
- Average True Range (ATR)
- CBUS 0.14
- GUTS 0.16
- MACD
- CBUS 0.02
- GUTS -0.05
- Stochastic Oscillator
- CBUS 62.07
- GUTS 16.15
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.